Sunshine Biopharma Inc. Impairment of Intangible Assets (Excluding Goodwill)
Sunshine Biopharma Inc. (SBFM) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-13
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2025-06-30 was $1.06M.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2014-12-31 was $0.00.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for the quarter ending 2014-09-30 was $0.00.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for fiscal 2014 was $0.00.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for fiscal 2013 was $0.00.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for fiscal 2012 was $0.00.
- Sunshine Biopharma Inc. impairment of intangible assets (excluding goodwill) for fiscal 2011 was $0.00.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month | Impairment of Intangible Assets (Excluding Goodwill) 19 month | Impairment of Intangible Assets (Excluding Goodwill) 22 month | Impairment of Intangible Assets (Excluding Goodwill) 25 month | Impairment of Intangible Assets (Excluding Goodwill) 28 month | Impairment of Intangible Assets (Excluding Goodwill) 31 month | Impairment of Intangible Assets (Excluding Goodwill) 34 month | Impairment of Intangible Assets (Excluding Goodwill) 37 month | Impairment of Intangible Assets (Excluding Goodwill) 40 month | Impairment of Intangible Assets (Excluding Goodwill) 43 month | Impairment of Intangible Assets (Excluding Goodwill) 49 month | Impairment of Intangible Assets (Excluding Goodwill) 55 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |||||||||||||
| 2025-06-30 | $1.06M 10-Q · filed 2026-08-13 | $1.06M 10-Q · filed 2026-08-13 | |||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $0.00 10-K · filed 2015-03-11 | |||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 4 quarters · filed 2015-03-11 | |||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $0.00 derived: sum of 4 quarters · filed 2015-03-11 | |||||||||||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $0.00 derived: sum of 4 quarters · filed 2015-03-11 | $945.98K 10-Q · filed 2014-05-09 | ||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | $0.00 10-K · filed 2015-03-11 | $945.98K 10-K · filed 2014-03-19 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $945.98K 10-Q · filed 2013-11-04 | |||||||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | |||||||||||||
| 2013-03-31 | $945.98K 10-Q · filed 2013-05-09 | ||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $945.98K 10-K · filed 2013-03-15 | ||||||||||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 | $945.98K 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-08 | $0.00 10-Q · filed 2012-08-08 | $0.00 derived: sum of 3 quarters · filed 2012-08-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 | $945.98K 10-Q · filed 2012-08-08 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2012-05-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 | $945.98K 10-Q · filed 2012-05-08 | ||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-19 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 10-K · filed 2012-03-19 | $945.98K 10-K · filed 2012-03-19 | ||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | -$945.97K derived: sum of 4 quarters · filed 2012-11-08 | $945.98K 10-Q · filed 2011-11-08 | ||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-08 | $0.00 10-Q · filed 2012-08-08 | -$945.97K derived: sum of 3 quarters · filed 2012-08-08 | -$895.97K derived: sum of 4 quarters · filed 2012-08-08 | $945.98K 10-Q · filed 2011-08-09 | ||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-08 | -$945.97K derived: sum of 2 quarters · filed 2012-05-08 | -$895.97K derived: sum of 3 quarters · filed 2012-05-08 | -$895.97K derived: sum of 4 quarters · filed 2012-05-08 | $945.98K 10-Q · filed 2011-05-12 | ||||||||||
| 2010-12-31 | -$945.97K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-19 | -$895.97K derived: sum of 2 quarters · filed 2012-03-19 | -$895.97K derived: sum of 3 quarters · filed 2012-03-19 | $0.00 10-K · filed 2012-03-19 | |||||||||||
| 2010-09-30 | $50.00K 10-Q · filed 2011-11-08 | $50.00K derived: sum of 2 quarters · filed 2011-11-08 | $945.97K 10-Q · filed 2011-11-08 | ||||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-09 | $50.00K 10-Q · filed 2011-08-09 | |||||||||||||
| 2010-03-31 | $50.00K 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |